tiprankstipranks
Gain Therapeutics Leadership Changes and Executive Compensation
Company Announcements

Gain Therapeutics Leadership Changes and Executive Compensation

Don't Miss Our Christmas Offers:

Gain Therapeutics (GANX) has shared an update.

Matthias Alder, CEO of Gain Therapeutics, Inc., mutually agreed to step down on June 25, 2024, to explore new opportunities, triggering his automatic resignation from the Board. In his exit, Alder received a separation package including a year’s salary and continued benefits. Meanwhile, Gene Mack, the CFO, stepped in as Interim CEO without additional pay, and Dr. Khalid Islam was appointed as Executive Chairman to supervise Board performance and support the new interim executive leadership.

See more insights into GANX stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyGain initiated with Buy on Parkison’s potential at Roth MKM
TheFlyGain Therapeutics initiated with a Buy at Roth MKM
TipRanks Auto-Generated NewsdeskGain Therapeutics Advances Parkinson’s Therapy Development
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App